Clinical trial by Moderna found no safety concerns with the COVID-19 vaccine in toddlers, contrary to claim by Joseph Ladapo
The emergence of the Omicron variant caused a spike in the number of COVID-19 cases and related hospitalizations among children aged six months to five years. Clinical trials involving thousands of participants showed that COVID-19 vaccines are safe and induce an immune response in children within this age group, which can prevent complications from the disease. Therefore, the American Academy of Pediatricians and the U.S. Centers for Disease Control and Prevention recommend that all children aged six months to five years receive the vaccine.